Reporting Manager
Alyeska Investment Group, L.P.
Symbol
CABA
Shares outstanding
96,359,743 shares
Disclosed Ownership
4,500,000 shares
Ownership
4.7%
Form type
SCHEDULE 13G/A
Filing time
17 Feb 2026, 16:33:50 UTC
Date of event
31 Dec 2025
Previous filing
14 Nov 2025

Sponsored

Quoteable Key Fact

"Alyeska Investment Group, L.P. disclosed 4.7% ownership in CABALETTA BIO, INC. Common Stock, par value $0.00001 per share (CABA) on 31 Dec 2025."

Quick Takeaways

  • Alyeska Investment Group, L.P. filed SCHEDULE 13G/A for CABALETTA BIO, INC. Common Stock, par value $0.00001 per share (CABA).
  • Disclosed ownership: 4.7%.
  • Date of event: 31 Dec 2025.

What Changed

  • Previous schedule filing date: 14 Nov 2025.
  • Current filing was accepted on 17 Feb 2026, 16:33.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Alyeska Investment Group, L.P. 4.7% 4,500,000 0 4,500,000 Jason Bragg Jason Bragg | Chief Financial Officer
Alyeska Fund GP, LLC 4.7% 4,500,000 0 4,500,000 Jason Bragg Jason Bragg | Chief Financial Officer
Anand Parekh 4.7% 4,500,000 0 4,500,000 Anand Parekh Anand Parekh | Self